Southridge Partners II Enters Into A $10 Million Equity Purchase Agreement With Musclepharm Corporation
November 07, 2011

RIDGEFIELD, CT, November 07, 2011 – Stephen Hicks, Managing Member of Southridge, announced today that Southridge Partners II LP ("Southridge"), an institutional investor, has entered into a $10 million equity purchase agreement with MusclePharm Corporation.

Headquartered in Colorado, MusclePharm Corporation (OTCBB: MSLP) is a healthy life-style company that develops and manufactures scientifically approved nutritional supplements to improve overall well-being and enhance athletic performance. Their products have been tested by professional athletes in various sports and have shown to be effective in weight loss, muscle building and general fitness. The company also has a line of apparel that is tied into its product mix and can be purchased online as well as through retail outlets where their nutritional supplements are sold.

The Company’s Management team is committed to profitably increasing their revenue stream through the introduction of new products as well as expanded channels of distribution.

Southridge seeks investments in emerging growth areas, domestically and in international markets. Southridge has successfully participated in providing over $1.7 billion in capital to companies in the United States, Asia, Canada, the United Kingdom and Australia amongst other markets.

About Southridge

Southridge is a diversified financial holding company specializing in direct investment and advisory services to small and middle market companies.

  Download PDF Version